| |
|
|
No 3 A1 Road 10
Shenyang Economy & Technology Development Zone
Shenyang, 110027
China
|
|
86 24 2581 1820
|
|
http://www.3sbio.com/
|
|
|
|
|
|
|
| Source: Company documents |
|
|
| Name
: |
Dan Lou |
| Title
: |
Chairman of the Board |
| Since: |
|
|
|
|
|
| Name
: |
Jing Lou |
| Title
: |
Chief Executive Officer, Director |
| Since: |
|
|
|
|
|
| Name
: |
Clara Mak |
| Title
: |
Chief Financial Officer |
| Since: |
06/2006 |
|
|
|
|
| Name
: |
Bin Huang |
| Title
: |
Vice President - Human Resources, Director |
| Since: |
|
|
|
|
|
| Name
: |
Liping Xu |
| Title
: |
Vice President, Director |
| Since: |
|
|
|
|
|
| Name
: |
Yingfei Wei |
| Title
: |
Vice President - Business Development, Chief Scientific Officer |
| Since: |
08/2006 |
|
|
|
|
| Name
: |
Dongmei Su |
| Title
: |
Chief Technology Officer |
| Since: |
|
|
|
|
|
| Name
: |
Yongfu Chen |
| Title
: |
Controller |
| Since: |
|
|
|
|
|
| Name
: |
Ke Li |
| Title
: |
Corporate Secretary |
| Since: |
|
|
|
|
|
|
|
|
| |
|
| Earnings
Release Dates : 14th May 2008 , 20th February 2008 , 13th November 2007 , 9th August 2007 |
|
 Audio |
|
|
| |
|
| |
|
| |
| Integra Acquires Eschelon Telecom for $566 M Mar 20, 3:24 PM EDT |
| Fortress’ IPO Climb 89% Feb 12, 5:49 PM EST |
|
| |
3Sbio Inc.
The Company’s product pipeline consists of six product candidates in various stages of development. The Company’s diversified product pipeline includes a number of next-generation protein-based therapeutics including NuPIAO, a second-generation EPIAO product candidate; NuLeusin, a next-generation Inleusin product candidate; TPIAO for the treatment of ITP; a human papilloma virus, or HPV, vaccine for the prevention of cervical cancer; and an anti-TNF humanized monoclonal antibody product candidate for the treatment of rheumatoid arthritis and other autoimmune diseases.
|
| More... |
|
|
|
